-
Covid-19 Protection Framework: Our offices are open. Visitors should sign-in, wear a mask, and follow social distance guidelines. Our contact details
GMD00102
Application overview
- Application code:
- GMD00102
- Application type:
- GM Development
- Applicant:
- University of Auckland
- Applicant postal address:
- Private Bag 92019, Victoria St West, Auckland Central, Auckland, 1142, New Zealand
- Application state:
- Decided
- Application decision:
- Approved with Controls
- Application purpose:
- To develop novel therapies for neurological disorders including Parkinson's Disease, epilepsy and injury resulting from stroke
- Decision notified date:
- 26 July 2000
- IBSC Reference:
- GMO00/UA032
Application documents
Substances or organisms in application
- Name:
- Escherichia coli (Migula 1895) Castellani & Chalmers 1919,
- Decision:
- Approved with Controls
- Synonyms:
- Approval number:
- GMD000475
- Trade names:
- Escherichia coli (bacteria, GM, development, IBSC, E. coli)
- Approval status:
- Approval expiry date:
- Application superceded by:
- Name:
- Mus musculus Linnaeus, 1758 cell lines
- Decision:
- Approved with Controls
- Synonyms:
- Approval number:
- GMD000476
- Trade names:
- Mus musculus (animal, vertebrate, mammal, GM, cell line, development, IBSC,mice)
- Approval status:
- Approval expiry date:
- Application superceded by:
- Name:
- Rattus norvegicus
- Decision:
- Approved with Controls
- Synonyms:
- Approval number:
- GMD000477
- Trade names:
- Rattus norvegicus (animal, vertebrate, mammal, GM, development, IBSC, wistar rat)
- Approval status:
- Approval expiry date:
- Application superceded by: